Handelsbanken Fonder
EWTX icon

Handelsbanken Fonder’s Edgewise Therapeutics EWTX Stock Holding History

Handelsbanken Fonder’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Sell
30,500
-600
-2% -$20.7K ﹤0.01% 1036
2026
Q1 		$980K Hold
31,100
– – ﹤0.01% 1052
2025
Q4 		$772K Sell
31,100
-7,300
-19% -$147K ﹤0.01% 1158
2025
Q3 		$623K Buy
38,400
+9,700
+34% +$138K ﹤0.01% 1194
2025
Q2 		$376K Buy
28,700
+6,900
+32% +$99.5K ﹤0.01% 1359
2025
Q1 		$480K Hold
21,800
– – ﹤0.01% 1256
2024
Q4 		$582K Buy
+21,800
New +$694K ﹤0.01% 1231

Other funds holding EWTX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Handelsbanken Fonder's EWTX Position: Q2 2026 in Review

Handelsbanken Fonder reduced its Edgewise Therapeutics (EWTX) stake by 1.9% in Q2 2026, selling an estimated $20.7K and leaving 30,500 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1036.

Handelsbanken Fonder first reported a position in EWTX in Q4 2024 and has held it in 7 quarters since. 37 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Handelsbanken Fonder held 30,500 shares of Edgewise Therapeutics worth $1.24M as of Q2 2026.
  • Handelsbanken Fonder sold 600 Edgewise Therapeutics shares in Q2 2026, an estimated $20.7K.
  • Edgewise Therapeutics made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1036 holding.
  • Handelsbanken Fonder first reported a position in Edgewise Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 37 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.